Here's the live share price of Solara Active Pharma Sciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Solara Active Pharma Sciences has declined 10.73% CAGR. Over the past year, the corresponding return has been -29.45%.
Solara Active Pharma Sciences’s current P/E of 102.46x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Solara Active Pharma Sciences | -5.89 | -5.76 | -5.60 | 17.07 | -29.20 | 11.38 | -10.73 |
| Sun Pharmaceutical Industries | -0.24 | 1.90 | 5.45 | -5.37 | -5.90 | 17.93 | 26.89 |
| Divi's Laboratories | 1.83 | 12.59 | 12.02 | 11.81 | 15.29 | 26.25 | 16.45 |
| Cipla | -0.11 | -0.91 | 0.58 | -0.59 | -4.66 | 9.87 | 13.57 |
| Torrent Pharmaceuticals | 0.26 | 0.71 | -0.79 | 8.47 | 12.95 | 28.56 | 22.33 |
| Dr. Reddy's Laboratories | 0.61 | -3.53 | 0.36 | 3.88 | -6.38 | 10.34 | 3.97 |
| Mankind Pharma | -3.07 | -6.97 | -9.16 | -4.98 | -15.31 | 17.48 | 10.15 |
| Zydus Lifesciences | -3.93 | -5.21 | -0.96 | 5.58 | -3.74 | 27.58 | 16.13 |
| Lupin | -0.42 | 1.63 | 0.50 | -5.55 | -7.32 | 40.20 | 15.88 |
| Alkem Laboratories | 2.23 | 2.58 | 15.41 | 11.87 | -1.60 | 20.43 | 15.41 |
| Aurobindo Pharma | 0.17 | 4.66 | 6.66 | -4.72 | -15.55 | 26.97 | 7.60 |
| Abbott India | 1.64 | -1.24 | -10.03 | -2.58 | 4.20 | 15.11 | 13.31 |
| Laurus Labs | 2.63 | 13.51 | 16.88 | 60.49 | 97.93 | 28.27 | 28.27 |
| Biocon | 3.49 | 10.62 | 5.60 | 11.08 | 17.32 | 11.44 | -1.40 |
| Glenmark Pharmaceuticals | -4.21 | -7.73 | -12.24 | 26.12 | 9.23 | 62.37 | 28.89 |
| GlaxoSmithKline Pharmaceuticals | -0.93 | -5.08 | -2.96 | -8.70 | -0.40 | 24.74 | 12.99 |
| Anthem Biosciences | -1.96 | -10.39 | -7.20 | -4.64 | -4.64 | -1.57 | -0.95 |
| Ipca Laboratories | 2.13 | -4.44 | -6.58 | -4.74 | -16.58 | 12.80 | 1.87 |
| Ajanta Pharma | 4.17 | 4.28 | -1.86 | 2.80 | -14.00 | 27.23 | 19.02 |
| Gland Pharma | -1.31 | -1.82 | -2.71 | 35.68 | 5.40 | 1.74 | 0.90 |
Over the last one year, Solara Active Pharma Sciences has declined 29.20% compared to peers like Sun Pharmaceutical Industries (-5.90%), Divi's Laboratories (15.29%), Cipla (-4.66%). From a 5 year perspective, Solara Active Pharma Sciences has underperformed peers relative to Sun Pharmaceutical Industries (26.89%) and Divi's Laboratories (16.45%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 595.82 | 611.85 |
| 10 | 595.38 | 605.62 |
| 20 | 596 | 605.99 |
| 50 | 627.81 | 614.57 |
| 100 | 619.79 | 609.34 |
| 200 | 569.06 | 598.86 |
In the latest quarter, Solara Active Pharma Sciences remained same as its previous close in promoter holding, while DII stake increased to 2.69%, FII holding fell to 13.58%, and public shareholding moved up to 41.71% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 4,20,000 | 0.11 | 25.32 | |
| 1,46,107 | 0.82 | 8.81 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Nov 06, 2025, 11:56 PM IST | Solara Active Pharma - Announcement under Regulation 30 (LODR)-Monitoring Agency Report |
| Nov 05, 2025, 11:56 PM IST | Solara Active Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Nov 05, 2025, 9:08 PM IST | Solara Active Pharma - General-Updates |
| Nov 05, 2025, 8:49 PM IST | Solara Active Pharma - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Nov 05, 2025, 8:46 PM IST | Solara Active Pharma - Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended Septemb |
Solara Active Pharma Sciences Ltd. is a Public Limited Listed company incorporated on 23/02/2017 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH2017PLC291636 and registration number is 291636. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 1283.76 Cr. and Equity Capital is Rs. 40.25 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Solara Active Pharma Sciences is ₹564.75 as on Nov 06, 2025.
The Solara Active Pharma Sciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Solara Active Pharma Sciences is ₹2,512.43 Cr as on Nov 06, 2025.
Today’s highest and lowest price of Solara Active Pharma Sciences are ₹575.55 and ₹542.95.
The 52-week high/low is the highest and lowest price at which Solara Active Pharma Sciences stock has traded in the past 52-week or nearly a year. The 52-week high of Solara Active Pharma Sciences is ₹885.95 and 52-week low of Solara Active Pharma Sciences is ₹441.10 as on Nov 06, 2025.
The Solara Active Pharma Sciences has shown returns of -8.53% over the past day, -7.56% for the past month, -4.96% over 3 months, -29.45% over 1 year, 11.38% across 3 years, and -10.73% over 5 years.
P/E ratio of and PB ratio of Solara Active Pharma Sciences are 102.46 and 2.30 on Nov 06, 2025. While the company gives a dividend yield of 0.00 per annum.